Heterogeneous burden of lung disease in smokers with borderline airflow obstruction
Authors:
- Cheryl S. PirozziCPCheryl S. Pirozzi
- Tian GuTGTian Gu
- Pedro M. QuibreraPQPedro M. Quibrera
- Elizabeth E. CarrettaECElizabeth E. Carretta
- MeiLan K. HanMHMeiLan K. Han
- Susan MurraySMSusan Murray
- Christopher B. CooperCCChristopher B. Cooper
- Donald P. TashkinDTDonald P. Tashkin
- Eric C. KleerupEKEric C. Kleerup
- Igor BarjaktarevicIBIgor Barjaktarevic
- Eric A. HoffmanEHEric A. Hoffman
- Carlos H. MartinezCMCarlos H. Martinez
Open Access
- 20 November 2018
- journal article
- research article
- Published by Springer Nature in Respiratory Research
- Vol. 19 (1) , 1-10
Abstract
The identification of smoking-related lung disease in current and former smokers with normal FEV1 is complex, leading to debate regarding using a ratio of forced expiratory volume in 1 s to forced vital capacity (FEV1/FVC) of less than 0.70 versus the predicted lower limit of normal (LLN) for diagnosis of airflow obstruction. We hypothesized that the discordant group of ever-smokers with FEV1/FVC between the LLN and 0.70 is heterogeneous, and aimed to characterize the burden of smoking-related lung disease in this group. We compared spirometry, chest CT characteristics, and symptoms between 161 ever-smokers in the discordant group and 940 ever-smokers and 190 never-smokers with normal FEV1 and FEV1/FVC > 0.70 in the SPIROMICS cohort. We also estimated sensitivity and specificity for diagnosing objective radiographic evidence of chronic obstructive pulmonary disease (COPD) using different FEV1/FVC criteria thresholds. The discordant group had more CT defined emphysema and non-emphysematous gas trapping, lower post-bronchodilator FEV1 and FEF25–75, and higher respiratory medication use compared with the other two groups. Within the discordant group, 44% had radiographic CT evidence of either emphysema or non-emphysematous gas trapping; an FEV1/FVC threshold of 0.70 has greater sensitivity but lower specificity compared with LLN for identifying individuals with CT abnormality. Ever-smokers with normal FEV1 and FEV1/FVC < 0.70 but > LLN are a heterogeneous group that includes significant numbers of individuals with and without radiographic evidence of smoking-related lung disease. These findings emphasize the limitations of diagnosing COPD based on spirometric criteria alone.Keywords
Funding Information
- National Heart, Lung, and Blood Institute (HHSN268200900013C, HHSN268200900014C, HHSN268200900015C, HHSN268200900016C, HHSN268200900017C, HHSN268200900018C HHSN268200900019C, HHSN268200900020C)
- National Institutes of Health (R01 HL122438)
- National Institutes of Health (K24 HL138188)
- Foundation for the National Institutes of Health
This publication has 41 references indexed in Scilit:
- Design of the Subpopulations and Intermediate Outcomes in COPD Study (SPIROMICS): Table 1Thorax, 2013
- Computed Tomography Structural Lung Changes in Discordant Airflow LimitationPLOS ONE, 2013
- CT Air Trapping Is Independently Associated with Lung Function Reduction over TimePLOS ONE, 2013
- Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2013
- Computed tomography–based biomarker provides unique signature for diagnosis of COPD phenotypes and disease progressionNature Medicine, 2012
- Small-Airway Obstruction and Emphysema in Chronic Obstructive Pulmonary DiseaseNew England Journal of Medicine, 2011
- Chronic obstructive pulmonary disease in older persons: A comparison of two spirometric definitionsRespiratory Medicine, 2010
- Development and first validation of the COPD Assessment TestEuropean Respiratory Journal, 2009
- Comparison of spirometry criteria for the diagnosis of COPD: results from the BOLD studyEuropean Respiratory Journal, 2009
- Chronic obstructive pulmonary disease in the older adult: what defines abnormal lung function?Thorax, 2007